<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="860">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03095677</url>
  </required_header>
  <id_info>
    <org_study_id>CHRO-2015-01</org_study_id>
    <nct_id>NCT03095677</nct_id>
  </id_info>
  <brief_title>Acute and Chronic Effects of Dynamic Apnea in Healthy Untrained Subjects</brief_title>
  <acronym>APNEX</acronym>
  <official_title>Acute and Chronic Effects of Dynamic Apnea in Healthy Untrained Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional d'Orléans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Unité de Recherche CIAMS - EA 4532</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Régional d'Orléans</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The inclusion of short periods of apnea (several seconds) during exercise (i.e. dynamic
      apnea) induces a significant decrease in blood oxygenation and muscle tissue. To date, the
      immediate effects (&quot;acute apnea&quot;) of this decrease in the quantity of oxygen available at
      the muscle and brain level are poorly understood. Moreover, a physical training during which
      these short periods of apnea (&quot;chronic apnea&quot;) would be included could lead to physiological
      adaptations and to improvement in physical performance similar to those obtained during
      altitude training.

      The purpose of this study is to evaluate the effects of acute dynamic apnea on metabolism.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spectometry to measure hemoglobin rate</measure>
    <time_frame>3 weeks</time_frame>
    <description>Measurement of oxygenation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wingate test to measure maximum consumption of dioxygen</measure>
    <time_frame>3 weeks</time_frame>
    <description>Measurement of aerobic performance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of hormonal markers</measure>
    <time_frame>3 weeks</time_frame>
    <description>Measurement of Dehydroepiandrostenedione (DHEA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Jaeger debimeter system to measure of peak oxygen</measure>
    <time_frame>3 weeks</time_frame>
    <description>Measurement of oxygen consumptiom</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of arterial saturation in dioxygen</measure>
    <time_frame>3 weeks</time_frame>
    <description>Measurement by ear blood micro-sample</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spectometry to measure hemoglobin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measurement of oxygenation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of hormonal markers</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measurement of Dehydroepiandrostenedione (DHEA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Jaeger debimeter system to measure of peak oxygen</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measurement of oxygen consumption,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of arterial saturation in dioxygen</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measurement by ear blood micro-sample</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac frequency</measure>
    <time_frame>3 weeks</time_frame>
    <description>measurement with a 12 lead - Electrocardiogamm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac frequency</measure>
    <time_frame>12 weeks</time_frame>
    <description>measurement with a 12 lead - Electrocardiogramm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Borg scale to measure penibility of the effort</measure>
    <time_frame>week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Borg scale to measure penibility of the effort</measure>
    <time_frame>week 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Apnea</condition>
  <arm_group>
    <arm_group_label>Apnea Group (GApn)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Program of training with exercises including apneas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group (GC)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Program of training with exercises without apnea</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Program of training with exercises including apnea</intervention_name>
    <description>16 training session on cycle ergometry with exercises including apneas.</description>
    <arm_group_label>Apnea Group (GApn)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Program of training with exercises without apnea</intervention_name>
    <description>16 training session on cycle ergometry with exercises without apnea</description>
    <arm_group_label>Control Group (GC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The cutaneous thickness at the vastus lateralis level lower than 1.5 cm to obtain the
             reliable muscle oxygenation measurement

          -  Subjects will have to sign the inform consent before the beginning of the study

        Exclusion Criteria:

          -  Contraindications to regular physical exercise practice

          -  To practice an endurance sport more than 1h/week

          -  Regular practice of apnea

          -  Chronic use of cannabis and/or alcohol

          -  Cardiac or metabolic pathology

          -  Asthma and/or bronchodilatator treatment

          -  ECG abnormality at rest

          -  Regular consumption of tobacco
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virgile AMIOT, Ph</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR ORLEANS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Virgile AMIOT, Ph</last_name>
    <phone>33 2 38 51 47 85</phone>
    <email>virgile.amiot@chr-orleans.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurélie DESPUJOLS</last_name>
    <phone>33 2 38 74 40 71</phone>
    <email>aurelie.despujols@chr-orleans.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHR d'Orléans</name>
      <address>
        <city>Orléans La Source</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice PRIEUR, PhD</last_name>
      <email>fabrice.prieur@univ-orleans.fr</email>
    </contact>
    <investigator>
      <last_name>Virgile AMIOT, Ph</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Andersson JP, Linér MH, Rünow E, Schagatay EK. Diving response and arterial oxygen saturation during apnea and exercise in breath-hold divers. J Appl Physiol (1985). 2002 Sep;93(3):882-6.</citation>
    <PMID>12183481</PMID>
  </reference>
  <reference>
    <citation>Caquelard F, Burnet H, Tagliarini F, Cauchy E, Richalet JP, Jammes Y. Effects of prolonged hypobaric hypoxia on human skeletal muscle function and electromyographic events. Clin Sci (Lond). 2000 Mar;98(3):329-37.</citation>
    <PMID>10677392</PMID>
  </reference>
  <reference>
    <citation>de Bruijn R, Richardson M, Schagatay E. Increased erythropoietin concentration after repeated apneas in humans. Eur J Appl Physiol. 2008 Mar;102(5):609-13. Epub 2007 Dec 19.</citation>
    <PMID>18097682</PMID>
  </reference>
  <reference>
    <citation>Dufour SP, Ponsot E, Zoll J, Doutreleau S, Lonsdorfer-Wolf E, Geny B, Lampert E, Flück M, Hoppeler H, Billat V, Mettauer B, Richard R, Lonsdorfer J. Exercise training in normobaric hypoxia in endurance runners. I. Improvement in aerobic performance capacity. J Appl Physiol (1985). 2006 Apr;100(4):1238-48.</citation>
    <PMID>16540709</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 30, 2017</lastchanged_date>
  <firstreceived_date>September 27, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dynamic apnea</keyword>
  <keyword>muscle oxygenation</keyword>
  <keyword>physical performance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
